✦ LIBER ✦

A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma

✍ Scribed by Chauhan, D; Velankar, M; Brahmandam, M; Hideshima, T; Podar, K; Richardson, P; Schlossman, R; Ghobrial, I; Raje, N; Munshi, N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ABT-737, an inhibitor of Bcl-2 family pr

✍ Kline, M P; Rajkumar, S V; Timm, M M; Kimlinger, T K; Haug, J L; Lust, J A; Grei 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 646 KB

‘Seed’ analysis of off-target siRNAs rev

✍ Lin, X; Morgan-Lappe, S; Huang, X; Li, L; Zakula, D M; Vernetti, L A; Fesik, S W 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 180 KB

Apoptosis-based treatment of glioblastom

✍ Tagscherer, K E; Fassl, A; Campos, B; Farhadi, M; Kraemer, A; Böck, B C; Macher- 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 628 KB

Antisense and nonantisense effects of an

✍ Kim, R; Emi, M; Matsuura, K; Tanabe, K 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 340 KB

The Bcl-2 inhibitor ABT-263 enhances the

✍ Scott Ackler; Michael J. Mitten; Kelly Foster; Anatol Oleksijew; Marion Refici; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 683 KB